Randomized, OpenLabel, Phase 3 Trial of Nivolumab Plus Ipilimumab or Nivolumab Plus Platinum Doublet Chemotherapy Versus Platinum Doublet Chemotherapy in Early Stage NSCLC
收藏DataCite Commons2025-12-10 更新2026-05-07 收录
下载链接：
https://search.vivli.org/doiLanding/studies/PR00012121/isLanding
下载链接
链接失效反馈官方服务：
资源简介：
The purpose of this neoadjuvant study is to compare nivolumab plus chemotherapy and chemotherapy alone in terms of safety and effectiveness, and to describe nivolumab plus ipilimumab's safety and effectiveness in treating resectable NSCLC.This study has multiple primary endpoints.
提供机构：
Vivli
创建时间：
2025-12-10
